Clinical trial · Interventional
Acceptance and Commitment Therapy (ACT) for Anxious Cancer Survivors
A Novel Acceptance-Based Intervention for Anxious Cancer Survivors
NCT02550925CI-TRIAL-00044265completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This randomized clinical trial compares group acceptance and commitment therapy (ACT) to usual care for cancer survivors experiencing anxiety following the end of cancer treatment.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Acceptance and Commitment Therapy (ACT) Group | Behavioral | — | UNRESOLVED |
| Usual Care | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Acceptance and Commitment Therapy Group
- interventionNames
- Behavioral: Acceptance and Commitment Therapy (ACT) Group
- type
- ACTIVE_COMPARATOR
- label
- Usual Care
- interventionNames
- Behavioral: Usual Care
Primary outcomes (1)
- measure
- Anxiety symptoms
- timeFrame
- Baseline to Post and (3- and 6-month) Follow Up
- description
- Method of assessment: questionnaire
Secondary outcomes (6)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 21 Years
- Maximum age
- 95 Years
Show eligibility criteria text
Inclusion Criteria: 1. Adults in the Greater Boulder/ Denver, Colorado area who had cancer and completed primary cancer treatment (surgery, chemotherapy, and/or radiation) within the previous 18 months 2. For solid tumor cancers: Show no current evidence of disease for solid-tumor cancers (of any cancer type or initial stage). For lymphoproliferative disorders such as chronic lymphocytic leukemia and indolent non-Hodgkin's lymphoma: In remission or asymptomatic after initial treatment and are followed with active surveillance. 3. Screen positive for anxiety symptoms on the study screener 4. Able to speak, read, and write English fluently 5. Willing and able to participate in an ACT group once a week for 7 weeks 6. Willing and able to complete online questionnaires and phone interviews at designated assessment points Exclusion Criteria: 1. Current moderate to high suicide risk 2. History of chronic untreated trauma (unrelated to their cancer) 3. Psychiatric hospitalization or suicide attempt in the past 5 years
References
Publications (3)
- BACKGROUNDArch JJ, Mitchell JL. An Acceptance and Commitment Therapy (ACT) group intervention for cancer survivors experiencing anxiety at re-entry. Psychooncology. 2016 May;25(5):610-5. doi: 10.1002/pon.3890. Epub 2015 Jun 29. No abstract available. PMID 26130586
- DERIVEDArch JJ, Mitchell JL, Genung SR, Judd CM, Andorsky DJ, Bricker JB, Stanton AL. Randomized trial of acceptance and commitment therapy for anxious cancer survivors in community clinics: Outcomes and moderators. J Consult Clin Psychol. 2021 Apr;89(4):327-340. doi: 10.1037/ccp0000630. PMID 34014694
- DERIVEDArch JJ, Mitchell JL, Genung SR, Fisher R, Andorsky DJ, Stanton AL. A randomized controlled trial of a group acceptance-based intervention for cancer survivors experiencing anxiety at re-entry ('Valued Living'): study protocol. BMC Cancer. 2019 Jan 18;19(1):89. doi: 10.1186/s12885-019-5289-x. PMID 30658621